J&J unit gets supplemental FDA OK for hip replacement device

04/29/2013 | MassDevice.com (Boston)

DePuy Orthopaedics, a unit of Johnson & Johnson, has received supplemental premarket approval from the FDA for a 36-millimeter version of its Ceramax Ceramic Total Hip System. The implantable device was first approved in 2010 for noncemented use in adult patients receiving total hip replacements.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX